Upcoming IPO Calendar
Company Name/Ticker Underwriter Price Range
Shares
American Addiction Centers
AAC
William Blair
Raymond James
$12.00 - $14.00
5.0 mil
Atento
ATTO
Morgan Stanley
Credit Suisse
$19.00 - $22.00
14.6 mil
Calithera Biosciences
CALA
Citi
Leerink Partners
$13.00 - $15.00
6.0 mil
Dave & Busters Entertainment
PLAY
Jefferies & Co.
Piper Jaffray
$16.00 - $18.00
5.9 mil
Dermira
DERM
Citi
Leerink Partners
$14.00 - $16.00
5.4 mil
Diplomat Pharmacy
DPLO
Credit Suisse
Morgan Stanley
$14.00 - $16.00
13.3 mil
EyeGate Pharmaceuticals
EYEG
Aegis Capital Corp.
$12.00 - $14.00
1.9 mil
Fairmount Santrol*
FMSA
Morgan Stanley
Wells Fargo Securities
$21.00 - $24.00
44.5 mil
HubSpot
HUBS
Morgan Stanley
J.P. Morgan
$19.00 - $21.00
5.0 mil
JP Energy Partners LP
JPEP
Barclays
BofA Merrill Lynch
$19.00 - $21.00
13.8 mil
MOL Global
MOLG
Citi
Deutsche Bank
$12.50 - $14.50
19.5 mil
NeuroSigma
NSIG
Jefferies & Co.
BTIG
$13.00 - $15.00
3.6 mil
OM Asset Management
OMAM
BofA Merrill Lynch
Morgan Stanley
$15.00 - $17.00
22.0 mil
rEVO Biologics
RBIO
Piper Jaffray
Guggenheim Securities
$13.00 - $15.00
3.6 mil
USD Partners LP
USDP
Citi
Barclays
$19.00 - $21.00
8.9 mil
Veritex Holdings
VBTX
Sandler O'Neill
Stephens Inc.
$12.00 - $14.00
2.7 mil
Viking Therapeutics
VKTX
Oppenheimer & Co.
Roth Capital
$10.00 - $12.00
5.0 mil
Vivint Solar
VSLR
Goldman Sachs
BofA Merrill Lynch
$16.00 - $18.00
20.6 mil
VWR
VWR
BofA Merrill Lynch
Goldman Sachs
$22.00 - $25.00
25.5 mil
Wayfair
W
Goldman Sachs
BofA Merrill Lynch
$25.00 - $28.00
11.0 mil
Yodlee
YDLE
Goldman Sachs
Credit Suisse
$11.00 - $13.00
6.3 mil

Notes:
Fairmount Santrol - *Filed with the SEC under the name FMSA Holdings.
Please note our calendar only lists IPOs scheduled for the coming week. For a more in-depth calendar, please inquire about our institutional research service.
IPOs For Everyone Obtain Investor PacketAccess Your AccountInvest Online Today
Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.

As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees. An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE. The S&P 500 index components are determined by S&P Dow Jones Indices.

Risk Disclosure: Investments in the Renaissance IPO ETF, symbol "IPO" (the “ETF”) and the Global IPO Fund, symbol "IPOSX" (the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETF and the Mutual Fund (the “Funds”) invest in companies that have recently completed their initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. The Funds may also be subject to information technology risk and small and mid-capitalization company risk due to a greater number of IPOs in these sectors. The Funds may hold securities in the form of Depository Receipts, REITs, Master Limited Partnerships (MLPs) which have greater risks than common shares. The strategy has high portfolio turnover and securities lending risks. ETF returns may not match the return of the respective index. The ETF is classified as a non-diversified investment company and is subject to concentration risk.

Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with information about the Funds, please visit www.renaissancecapital.com. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETF, 1-866-486-6645.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.